Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies.
D'Souza
M Patricia
MP
Division of AIDS, the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. pdsouza@niaid.nih.gov
Frahm
Nicole
N
D016915:AIDS Vaccines / Q000276:immunology; D000256:Adenoviridae / Q000276:immunology* / Q000472:pathogenicity; D000914:Antibodies, Viral / Q000276:immunology; D005822:Genetic Vectors; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D007156:Immunologic Memory / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology
D016915:AIDS Vaccines; D000914:Antibodies, Viral